Xu, Yichen
University of California, San Francisco · UCSF Helen Diller Family Comprehensive Cancer Center
3 papers on CoChatORCID 0000-0002-3619-2302
Most cited papers
- Verified
Translation control of the immune checkpoint in cancer and its therapeutic targeting
Xu, Y., Poggio, M., Jin, H. Y., Shi, Z., Forester, C. M., Wang, Y., Stumpf, C. R., Xue, L., Devericks, E., So, L., et al. (2019) · Nature Medicine
Cancer Immunotherapy and BiomarkersRNA and protein synthesis mechanisms
Cited by 261
- Verified
Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A
Pan, B., Chen, Y., Song, H., Xu, Y., Wang, R., & Chen, L. (2015) · Oncotarget
MicroRNA in disease regulationAutophagy in Disease and Therapy
Cited by 103
- Verified
The Role of Translation Control in Tumorigenesis and Its Therapeutic Implications
Xu, Y., & Ruggero, D. (2020) · Annual Review of Cancer Biology
RNA and protein synthesis mechanismsPI3K/AKT/mTOR signaling in cancer
Cited by 67
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free